Commercial positioning case studies

Increasing the reach and return on investment in your clinical data with innovative solutions

Learn more about our commercialisation & outcomes expertise in this case study library.

We help pharma, device, and biotechnology companies at every stage of development—from endpoint selection and PRO development, through clinical trials, to post-approval and scientific publication.

Exceeding late phase study recruitment goals

Over 19 days, 91黑料 conducted a focused site engagement programme to increase patient screening and accelerate enrolment of a late phase multinational, multicentre study to evaluate a treatment for pulmonary disease.
Read more

Enhancing the impact of scientific posters

The 91黑料 global medical communications group worked with a large pharmaceutical company to identify ways to engage the congress audience and expand the impact of their scientific presentations at a large international meeting.
Read more

Voice & speech recognition

91黑料 Outcome Measures found well-validated tools for processing data associated with speech cadence, vocal pitch, and similar measures to evaluate rates of change in neurologic and psychiatric disorders.
Read more

Patient cardiac safety

A digital health lead at a large pharmaceutical company came to 91黑料 Outcome Measures to find a wearable that could capture continuous cardiac rhythms and be used to detect QT prolongation.
Read more

Launching into an established market

91黑料 Market Access played a key role in informing a client’s go-to-market strategy, including analytics around market sizing, a competitive landscape assessment and a benefit design analysis for a long-acting, injectable anti-psychotic drug.
Read more

Chronic Myeloid Leukaemia

As a result of the multifaceted communication approach with sites and a strong partnership between 91黑料 and sponsor, the study met its protocol-specified enrolment goal just 9 days beyond contracted Last Patient In date (LPI).
Read more